Caricamento...
Tailoring precision immunotherapy: coming to a clinic soon?
Cell-based and antibody-based cancer immunotherapies have been widely tested across increasing numbers of cancers with an unprecedented number of successful practice-changing immunotherapy clinical trials, achieving significant survival outcomes and, characteristically, some very long-term survivors...
Salvato in:
| Pubblicato in: | ESMO Open |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7046383/ https://ncbi.nlm.nih.gov/pubmed/33558033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2019-000631 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|